Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

59
Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center

Transcript of Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Page 1: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Stroke:An Introduction

Maarten Lansberg, MD, PhDNeil Schwartz, MD, PhD

Stanford Stroke Center

Page 2: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Outline

• Background

• Stroke Diagnosis

• Stroke Treatment

• Stroke Prevention

Page 3: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

What is a Stroke? (Brain Attack)

Disruption of blood flow to part of the brain caused by:

• Occlusion of a blood vessel (ischemic stroke)

OR• Rupture of a blood vessel

(hemorrhagic stroke)

Page 4: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Types of Stroke

6%

10%

31%

53%

84%

0% 20% 40% 60% 80% 100%

Subarachnoid

Intracerebral

Embolic

Thrombotic

Total Ischemic

IschemicHemorrhagic

Mohr JP, Caplan LR, Melski JW, et al. Neurology 1978;28:754-62

Page 5: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Anatomy

Page 6: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.
Page 7: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

MR Angiogram

Page 8: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

What happens with cutoff of blood supply?

Oxygen deprivation to nerve cells in the affected area of the brain -->

Nerve cells injured and die --> The part of the body controlled

by those nerve cells cannot function.

Page 9: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

What Causes Ischemic Stroke?

Thrombotic

Embolic

Thrombus

Embolus

Page 10: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Ischemic Stroke

Page 11: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.
Page 12: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

What happens with rupture of a blood vessel?

Oxygen deprivation to nerve cells in the affected area of the brain and local destruction of nerve cells-->

Nerve cells injured and die --> The part of the body controlled by

those nerve cells cannot function.

Page 13: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Intracerebral Hemorrhage

Page 14: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.
Page 15: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.
Page 16: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Head CT: Ischemic or Hemorrhagic Stroke?

Page 17: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Head CT: Ischemic or Hemorrhagic Stroke?

Page 18: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Stroke Impact

• 750,000 strokes per year

• Third leading cause of death(1st: heart disease, 2nd: all cancers)

– Over 160,000 deaths per year

• Over 4 million stroke survivors

1. Williams GR, Jiang JG, Matchar DB, et al. Stroke 1999; 30:2523-28.2. Hoyert DL, Kochanek KD, Murphy SL. National Vital Statistics Report 1999; 47:19.

Page 19: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Stroke Impact (2)

• Leading cause of adult disability– Of those who survive, 90%

have deficit• Half of all patients hospitalized

for acute neurological disease.• Stroke costs the U.S. $30 to $40

billion per year.

Page 20: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

The Stroke Belt

Perry HM, Roccella EJ. Hypertension 1998;6:1206-15.

Page 21: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

2. Stroke Diagnosis

Page 22: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Symptoms of Stroke

• Sudden numbness or weakness of face, arm or leg, especially on one side of the body

• Sudden confusion, trouble speaking or understanding

• Sudden trouble seeing from one or both eyes

• Sudden unsteadiness, dizziness, loss of balance or coordination

• Sudden severe headache with no known cause

Page 23: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Other Stroke Symptoms

•Also common following stroke– Depression– Other emotional problems– Memory problems

Page 24: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Common Stroke Patterns

• Left (Dominant) Hemisphere:– Aphasia– Right hemiparesis– Right hemisensory loss– Right visual field defect– Left gaze preference– Dysarthria– Difficulty reading, writing, or

calculating

Page 25: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Common Stroke Patterns (2)

• Right (Nondominant) Hemisphere:– Left hemiparesis– Left hemisensory loss– Left neglect– Left visual field defect – Right gaze preference– Dysarthria

Page 26: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Common Stroke Patterns (3)

• Brainstem/Cerebellum/Posterior Circulation– Motor or sensory loss in all 4 limbs– Crossed signs (face vs. body)– Limb or gait ataxia– Dysarthria– Dysconjugate gaze– Nystagmus– Amnesia– Cortical blindness

Page 27: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Common Stroke Patterns (4)

• Small Vessel (Lacunar) Strokes (Subcortical or Brain Stem)– Pure Motor

•Weakness of face, arm, leg– Pure Sensory

•Decreased sensation of face, arm, leg

Page 28: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Differential Diagnosis• Stroke (ischemic; hemorrhagic)• Intracranial mass

– Tumor– Subdural hematoma

• Seizure with persistent neurological signs• Migraine with persistent neurological signs• Metabolic

– Hyper/Hypoglycemia• Infectious

– Meningitis / Encephalitis / Cerebral abscess– Systemic

Page 29: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

3. Stroke Treatment

Page 30: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Time is

Brain

Page 31: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

EMS/ED evaluation of acute stroke

• Assure adequate airway

• Monitor vital signs

• Conduct general assessment– Evidence of trauma to head or neck– Cardiovascular abnormalities

Page 32: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

EMS/ED evaluation of acute stroke (cont.)

• Conduct neurological examination

– Level of consciousness (Glasgow Coma Scale)

– Presence of seizure activity

– NIH Stroke Scale

Page 33: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

ED evaluation of acute stroke: diagnostic tests

• Non-contrast Head CT• EKG• Blood Glucose• CBC, platelets, PTT, PT/INR• Serum electrolytes

Page 34: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

t-PA therapy

Page 35: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

tPA therapy for acute stroke

• Candidate for IV tPA?– Stroke onset < 3 hours (When was

the patient last seen at baseline ?)

• Benefit: 12 % increased chance of good recovery

• Risk: bleeding (up to 6%)

Page 36: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

tPA exclusion criteria

– Symptoms mild or rapidly resolving– SBP > 180 or DBP > 110– Blood on head CT– History of ICH– CNS tumor or vascular malformation– Bacterial endocarditis– Known bleeding disorder– PTT > 40; PT > 15 (INR > 1.7)– Stroke within 3 months– Significant trauma in last 3 months – GI/GU/Resp hemorrhage within 21 days– Major surgery within 14 days / minor surgery

within 10 days– Peritoneal dialysis or hemodialysis– Seizure at onset of stroke– Glucose <50 or >400– Pregnant

Page 37: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Other therapies for acute stroke

• IV t-Pa outside the three hour window

• IA t-PA• IA mechanical

thrombolysis/thrombectomy

• Neuroprotective agents

Page 38: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Stroke Management

If not a candidate for acute intervention, then focus on:

– Prevention of recurrent stroke• Diagnostic evaluation for stroke etiology• Risk factor assessment

– Rehabilitation (PT/OT/SLP)

– Prevention of Complications• DVT, aspiration PNA, decubitus ulcers, falls

Page 39: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Diagnostic stroke evaluation• Purpose: Identify location, size, and cause of stroke• Tests may include:

– Follow-up head CT– Brain MRI/MRA– Carotid ultrasound– Cardiac echo (transthoracic or transesophageal)– Cerebral angiogram or CT angiogram– Lipid panel– Hemoglobin A1c– Hypercoagulable tests: antiphospholipid antibodies,

Protein C & S, Antithrombin III, Factor V Leiden mutation, Prothrombin 20210A mutation…

Page 40: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

4. Stroke Prevention

Page 41: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Stroke survivor’s greatest risk is another stroke

3%

7%

3%

14%13% 13%

10%

2%2

4

6

8

10

12

14

16

CATS TASS CAPRIE* ESPS 2

Pe

rce

nt o

f pa

tient

s w

ith e

vent

s

Stroke Heart Attack

Albers, G.W. Neurology. 2000;14;54(5):1022-8.

* Stroke patient subgroup only (n = 6,431)

Page 42: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Transient Ischemic Attack (TIA)

• Stroke symptoms resolve in less than 24 hours (most resolve in < 1 hour)

• Warning sign for stroke and heart attack– One third go on to have a stroke within 5

years

• Stroke risk can be reduced

• Opportunity to prevent full stroke

Page 43: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

• Age

• Gender (men)

• Heredity: family history of stroke, hypercoagulable states

• Race/ethnicity (e.g. African Americans)

Sacco RL, Benjamin EJ, Broderick JP, et al. Stroke: 1997;28:1507-17.

Stroke risk factorsNon - Modifiable

Page 44: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Stroke risk factors

Medical Conditions

• Hypertension

• Heart disease

• Atrial fibrillation

• High Cholesterol

• Diabetes

• Carotid stenosis

• Prior stroke or TIA

Behaviors Cigarette smoking Alcohol abuse Physical inactivity

Modifiable

Sacco RL. et al. Stroke. 1997;28:1507-1517 Pancioli AM et al. JAMA. 1998;279:1288-1292

Page 45: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

How many strokes can be prevented?*

360,000

146,000

90,000

69,000

34,000

0 100,000 200,000 300,000 400,000

Heavy AlcoholUse

AF

Smoking

Cholesterol

HTN

Adapted from Gorelick PB. Arch Neurol 1995;52:347-55

*Based on an estimated 731,000 strokes annually

Page 46: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

HypertensionJNC VII Guidelines

Page 47: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Lower blood pressure = Lower Risk

< 120/80

< 130/85

< 140/90

Car

diov

ascu

lar

Eve

nts

Vasan RS et al N Engl J Med 345; 1291-7, 2001

< 120/80

< 130/85

< 140/90

Car

diov

ascu

lar

Eve

nts

(%)

Page 48: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Progress, Lancet. 2001;358:1033-41

20

15

10

5

0 1 2 3 4

PROGRESS Trial

28% relative risk reduction

PlaceboActive

Follow-up time (years)

Str

oke

Rat

e (%

)

Blood pressure reduction following stroke

14%

10%

Page 49: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Risk factor modificationsfor blood lipids

National Cholesterol Education Program (NCEP) Guidelines

ConditionHyperlipidemia oratherosclerotic

disease(LDL >100 mg/dL)

Recommendation• Diet: decrease fat

and cholesterol• Exercise• Add pharmacologic

therapy: statin agents

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 1993;269:3015-23.

Page 50: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Risk factor modifications for DM

ADA Recommendations to Reduce Microvascular Complications

• Average pre-prandial glucose <120 mg/dL• Average bedtime glucose 100 to 140

mg/dL

• HbA1c <7%

1. Lukovitis TG, Mazzone T, Gorelick PB. Neuroepidemiology 1999;18:1-14.2. Diabetes Care 1998;21 (Suppl 1):1-200

Page 51: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Lifestyle Risk Factor ModificationsLifestyle Factor

• Cigarette Smoking

• Alcohol use

• Physical activity

• Diet

Recommendation• Counseling• Nicotine replacement therapy• Bupropion

• Up to 2 drinks/day for men, 1 drink/day for women, or lighter individuals

• Brisk activity (30 to 60 min/day)

• 5 servings/day fruit and vegetables• Limit saturated fat (<30% total energy)

Gorelick PB, Sacco RL, Smith DB, eet al. JAMA 1999;281:1112-1120.

Page 52: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Prevention of Blood Clot Formation

Müller, 1997

Page 53: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Medications that prevent stroke

“Blood thinners”Antiplatelet Agents

•Aspirin

•Aspirin/extended release dipyridamole (Aggrenox)

•Clopidogril (Plavix)

•Ticlopidine (Ticlid)

Anticoagulants

•Coumadin (warfarin)

•Exanta

•Heparins

Page 54: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Aspirin for prevention of stroke

•Aspirin benefit independent of dose and gender

•FDA, AHA & ACCP all recommend– an aspirin dose between 50 and 325 mg/day

Albers GW at al Neurology 1999;53(suppl. 4):S25-S38 FDA. Federal Register. 1998;63:56802.Albers GW, et al. Chest 2001, 119: 300S-320S.

Page 55: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Choice of medication for stroke prevention

What is the cause of the stroke?

Atherosclerosis Unknown Heart

Warfarin

(Coumadin)

Antiplatelet therapy

Albers GW, et al. Chest 1998;114:683S-698SBarnett HJ et al. N Engl J Med. 1998;339:1415-1425

Page 56: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Prevention of recurrent stroke Stroke caused by atrial fibrillation

EAFT Study Group Lancet 1993, 342: 1255-62

66%

15%

80%

60%

40%

20%

0%

Benefit of warfarin

Benefit of aspirin

Relative Risk Reduction

Page 57: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

How to prevent a stroke

• Control treatable risk factors

• Take an anti-platelet agent or an anti-coagulant

• Surgical therapy for carotid stenosis

Page 58: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Changing the perception of stroke

MYTH

• Stroke is unpreventable

• Cannot be treated

• Strikes only the elderly

• Recovery ends 6 months after a stroke

REALITY

• Stroke is largely preventable

• Requires urgent treatment

• Can happen to anyone

• Stroke recovery can continue throughout life

Page 59: Stroke: An Introduction Maarten Lansberg, MD, PhD Neil Schwartz, MD, PhD Stanford Stroke Center.

Stroke Websites

American Stroke Association:www.strokeassociation.org

National Stroke Association:www.stroke.org

Stanford Stroke Centerwww.stanford.edu/group/neurology/stroke/